Trustees of Columbia University in the City of New York Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAPT
RAPT Therapeutics
RAPT
|
+$120K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$84.6M |
| 2 |
VIGL
Vigil Neuroscience
VIGL
|
+$1.53M |
| 3 |
HEICO Corp Class A
HEI.A
|
+$825K |
| 4 |
Vor Biopharma
VOR
|
+$40 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.31% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $653M | 99.69% |
980,596
-132,017
| -12% | -$84.6M |
|
2
Surrozen
SRZN
$283M
| $618K | 0.09% |
47,930
| – | – |
|
3
Tenaya Therapeutics
TNYA
$168M
| $473K | 0.07% |
291,828
| – | – |
|
4
Q32 Bio
QTTB
$463M
| $265K | 0.04% |
133,903
| – | – |
|
|
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
| $237K | 0.04% |
+9,172
| New | +$120K |
|
|
6
Vor Biopharma
VOR
$1.36B
| $224K | 0.03% |
4,595
-1
| -0% | -$40 |
|
7
Xilio Therapeutics
XLO
$59.8M
| $210K | 0.03% |
17,831
| – | – |
|
|
SRZNW
8
DELISTED
Surrozen Inc Warrant
SRZNW
| $517 | ﹤0.01% |
33,333
| – | – |
|
|
9
HEICO Corp Class A
HEI.A
$37.6B
| – | – |
-3,187
| Closed | -$825K |
|
|
VIGL
10
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-192,973
| Closed | -$1.53M |
|
Similar funds
Trustees of Columbia University in the City of New York's Q3 2025 Portfolio in Review
As of Q3 2025, Trustees of Columbia University in the City of New York held 10 positions worth $655M, down 5.2% from $691M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trustees of Columbia University in the City of New York withdrew a net $86.9M in Q3 2025, closing 2 positions and reducing 2 holdings. Its most notable exit was Vigil Neuroscience, an estimated $1.53M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0.31% of assets, down from 0.38% a quarter earlier, followed by Industrials.
Against the trend, Trustees of Columbia University in the City of New York opened a new position in RAPT Therapeutics worth $237K.
- Trustees of Columbia University in the City of New York's largest Q3 2025 buy was RAPT Therapeutics: 9,172 shares worth $237K.
- Trustees of Columbia University in the City of New York's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $84.6M.
- Trustees of Columbia University in the City of New York fully exited Vigil Neuroscience in Q3 2025, selling an estimated $1.53M.
- Trustees of Columbia University in the City of New York's ten largest holdings make up 100% of its $655M portfolio in Q3 2025.
- Trustees of Columbia University in the City of New York opened 1 new position and closed 2 in Q3 2025.
- Trustees of Columbia University in the City of New York's portfolio value fell 5.2% quarter-over-quarter to $655M.
Based on Trustees of Columbia University in the City of New York's 13F filing for Q3 2025, filed 14 Nov 2025.